
amplifyeP24
Scientifically formulated enzyme capsule, P24, enhancing protein bioaccessibility and nutrient absorption from dietary intake.
Date | Investors | Amount | Round |
---|---|---|---|
* | $18.5m | Series A | |
Total Funding | 000k |
Related Content
amplifye commercializes P24, a dietary supplement featuring a naturally sourced enzyme. This key ingredient, discovered in a Japanese hot spring, is delivered via a capsule intended for consumption with meals, particularly the largest one of the day.
The product's core function is to improve protein bioaccessibility—the extent to which nutrients can be accessed and absorbed by the body. P24 addresses the common challenge of inefficient protein utilization from food by initiating the digestive breakdown of proteins into smaller peptides and amino acids more effectively.
The development of P24 leverages Nobel Prize-winning scientific research. By enhancing protein absorption, the supplement aims to allow consumers to derive greater health benefits from the protein they consume.
amplifye operates in the nutritional supplement segment of the health and wellness market. The business model appears to be direct-to-consumer, with revenue generated from sales of the P24 enzyme capsules, facilitated through an online purchasing platform. The company also provides nutritional news and scientific content, likely to inform potential customers and build credibility.
Keywords: P24, enzyme supplement, protein absorption, bioaccessibility, nutritional science, dietary supplement, digestive aid, nutrient utilization, health and wellness, direct-to-consumer